GO:1903925 response to bisphenol A: Endocrine Disruption Response, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:1903925 (response to bisphenol A) describes any cellular or organismal process that changes state or activity following exposure to bisphenol A (BPA), including movement, secretion, enzyme production, and gene expression.
• BPA is an endocrine-disrupting chemical that can act at low doses and produce non-monotonic dose responses, meaning effects are not always proportional to dose.
• BPA exposure perturbs hepatic immune signaling, metabolomic pathways, and vascular reactivity, demonstrating that the response is multi-systemic.
• BPA and its analogues can trigger feed-forward estrogenic responses, amplifying hormonal signaling beyond a single receptor interaction.
• The response to BPA is studied using transcriptomics, metabolomics, immunology, and vascular physiology models, often with CRISPR-engineered cell and animal models.
• Understanding GO:1903925 helps researchers connect environmental exposure to disease mechanisms such as allergic inflammation, reproductive toxicity, and metabolic disruption.
Description
GO:1903925, response to bisphenol A, is a biological process Gene Ontology term that captures any change in a cell or organism following exposure to bisphenol A (BPA). The official definition states that it is any process that results in a change in state or activity of a cell or an organism, in terms of movement, secretion, enzyme production, gene expression, and similar outputs, as a result of a bisphenol A stimulus. This term is important because BPA is a widespread environmental contaminant and endocrine-disrupting chemical, and its biological effects are broad, dose-sensitive, and often non-linear. Researchers use GO:1903925 to annotate and interpret datasets where BPA exposure alters molecular and physiological readouts, from hepatic immune responses to vascular tone and metabolomic profiles. The response to BPA is not a single pathway but a network of cellular reactions. BPA can act through estrogen receptor-dependent and independent mechanisms, and it can induce feed-forward estrogenic responses that amplify hormonal signals. Low-dose effects and non-monotonic dose responses are well documented, meaning that small exposures may produce effects that are not predicted by high-dose studies. This complexity makes GO:1903925 a useful organizing concept for integrating data across transcriptomics, metabolomics, immunology, and physiology. For biomedical researchers, GO:1903925 provides a standardized way to describe and compare BPA-responsive phenotypes. It supports mechanistic studies of endocrine disruption, reproductive toxicity, immune dysregulation, and cardiovascular effects. It also enables cross-species comparisons, since BPA responses have been observed in rodents, fish, and human-relevant cell models. By anchoring experiments to a defined GO term, investigators can improve reproducibility and data reuse in environmental health research.
response to bisphenol A At A Glance
| GO ID | GO:1903925 |
|---|---|
| GO term | response to bisphenol A |
| Ontology | biological_process |
| Synonym | none |
| Major function | Captures changes in cell or organism state or activity following bisphenol A exposure, including movement, secretion, enzyme production, and gene expression. |
| Stimulus | Bisphenol A (BPA), an endocrine-disrupting chemical with low-dose and non-monotonic effects. |
| Key systems affected | Hepatic immune response, vascular reactivity, metabolomic pathways, reproductive tissues, and allergic inflammation. |
| Common research models | Rodent models, zebrafish, and human-relevant cell lines exposed to BPA or its analogues. |
| Related disease areas | Metabolic disruption, reproductive toxicity, cardiovascular dysfunction, and immune dysregulation. |
What Is GO:1903925?
In plain terms, GO:1903925 describes everything a cell or organism does differently after it encounters bisphenol A. The QuickGO definition specifies that this includes changes in movement, secretion, enzyme production, gene expression, and other state or activity changes triggered by a BPA stimulus. It is a biological process term, meaning it describes a series of molecular events rather than a single molecular function or a cellular component. The term has no synonyms in the provided QuickGO data. It is used to annotate genes, proteins, and pathways that respond to BPA exposure, and it helps researchers group diverse BPA-induced phenotypes under a single ontology label.
Why Is response to bisphenol A Important in Cell Biology?
GO:1903925 is important because bisphenol A is a ubiquitous environmental chemical and a model endocrine disruptor, and its biological effects are broad, dose-sensitive, and often non-monotonic. Researchers need a standardized ontology term to annotate and compare BPA-responsive genes, pathways, and phenotypes across experiments and species. The term supports mechanistic studies of endocrine disruption, immune modulation, vascular function, and reproductive toxicity, and it helps link environmental exposure to human disease risk.
• BPA is an endocrine-disrupting chemical with documented adverse health effects and complex toxicity mechanisms.
• BPA can modulate the hepatic immune response, linking exposure to liver immune dysregulation.
• BPA analogues can induce feed-forward estrogenic responses, amplifying hormonal signaling in vivo.
• Low-dose effects and non-monotonic dose responses make BPA biology unpredictable and dose-sensitive.
• BPA exposure alters the adult female prostate in rodent models, indicating reproductive tissue sensitivity.
• BPA modifies vasoactive responses in the middle cerebral artery, connecting exposure to cerebrovascular effects.
• Oral BPA exposure exacerbates allergic inflammation in a mouse food allergy model.
• Dose-response metabolomics can map molecular cartography and pathway sensitivity to BPA.
• GO:1903925 provides a standardized annotation target for BPA-responsive datasets across omics platforms.
• The term supports cross-species and cross-system comparisons in environmental health research.
What Happens During response to bisphenol A?
Exposure and cellular uptake
In simple terms: BPA enters the body or a cell, and the cell begins to respond.
The response to bisphenol A begins when an organism or cell is exposed to BPA. BPA is an environmental chemical that can act as an endocrine disruptor, and its adverse health effects depend on exposure route, dose, and timing. In experimental models, BPA is often administered orally or via controlled exposure, and it can reach multiple tissues including liver, reproductive organs, and vasculature. The initial encounter sets off a cascade of cellular changes that are captured by GO:1903925.
Receptor and signaling activation
In simple terms: BPA can switch on hormone-like signals, sometimes amplifying them.
BPA can interact with estrogen-related signaling and induce feed-forward estrogenic responses, meaning that the initial signal can be amplified through downstream pathways. This receptor and signaling activation is a central part of the response to BPA and helps explain why effects can be observed at low doses and why dose-response curves may be non-monotonic. The activation of these pathways leads to changes in gene expression and cellular activity that are annotated under GO:1903925.
Gene expression and enzyme production changes
In simple terms: The cell changes which genes and enzymes it makes.
A key output of the response to bisphenol A is altered gene expression and enzyme production. The QuickGO definition explicitly includes gene expression and enzyme production as examples of state or activity changes. Transcriptomic and metabolomic studies show that BPA exposure reshapes molecular pathways, and dose-response metabolomics can map pathway sensitivity and molecular cartography. These changes can affect immune signaling, metabolic pathways, and vascular function.
Immune and inflammatory modulation
In simple terms: BPA can change how the immune system reacts.
BPA exposure can modulate the hepatic immune response, indicating that the response to BPA includes immune-related changes. In a mouse model of food allergy, oral exposure to BPA exacerbated allergic inflammation, showing that the response can influence inflammatory outcomes. These findings link GO:1903925 to immune dysregulation and allergic disease mechanisms.
Vascular and physiological responses
In simple terms: BPA can change how blood vessels behave.
The response to bisphenol A extends to vascular physiology. BPA exposure modifies the vasoactive response of the middle cerebral artery, demonstrating that the process can alter vascular tone and cerebrovascular function. In rodent models, BPA exposure also affects reproductive tissues such as the adult female prostate. These physiological responses illustrate the multi-systemic nature of GO:1903925.
Metabolomic and pathway-level remodeling
In simple terms: BPA changes the cell's chemical landscape.
Dose-response metabolomics has been used to map molecular cartography and pathway sensitivity to BPA exposure, revealing that the response involves coordinated changes across metabolic pathways. This pathway-level remodeling is a core feature of GO:1903925 and provides a systems-level view of how BPA affects cells and organisms. It also helps researchers identify sensitive pathways and potential biomarkers of exposure.
Key Genes Involved in GO:1903925 response to bisphenol A
The following genes and proteins are representative of pathways and systems that respond to bisphenol A exposure, based on the verified literature provided.
| Gene | Major Role | Research Relevance |
|---|---|---|
| ESR1 | Estrogen receptor alpha, a key mediator of estrogenic signaling that BPA can influence | Central to understanding feed-forward estrogenic responses to BPA and its analogues. |
| ESR2 | Estrogen receptor beta, another estrogen signaling receptor | Helps dissect receptor-specific contributions to the response to BPA. |
| CYP1A1 | Cytochrome P450 enzyme involved in xenobiotic and estrogen metabolism | Metabolomic and pathway studies of BPA exposure often implicate metabolic enzymes. |
| CYP1B1 | Cytochrome P450 enzyme involved in estrogen and xenobiotic metabolism | Relevant to metabolic pathway sensitivity and molecular cartography of BPA exposure. |
| IL4 | Cytokine involved in allergic inflammation | BPA exposure exacerbates allergic inflammation in a food allergy model, implicating type 2 cytokines. |
| IL5 | Cytokine involved in eosinophilic inflammation | Allergic inflammation exacerbated by BPA may involve eosinophil-associated cytokines. |
| IL13 | Cytokine involved in allergic inflammation and mucus production | Relevant to BPA-exacerbated allergic responses in mouse models. |
| TNF | Pro-inflammatory cytokine | Hepatic immune response modulation by BPA may involve inflammatory cytokines. |
| IL6 | Pro-inflammatory cytokine | BPA can modulate hepatic immune signaling, and IL6 is a common readout of inflammatory changes. |
| NFKB1 | Transcription factor controlling inflammatory gene expression | Central to immune and inflammatory responses that BPA can modulate. |
| NR1H4 | Nuclear receptor FXR involved in bile acid and metabolic regulation | Metabolomic pathway sensitivity to BPA may involve nuclear receptor signaling. |
| PPARG | Nuclear receptor involved in lipid and glucose metabolism | BPA exposure can affect metabolic pathways, and PPARG is a key metabolic regulator. |
| NOS3 | Endothelial nitric oxide synthase, regulates vascular tone | BPA modifies vasoactive responses in cerebral arteries, implicating vascular signaling genes. |
| EDN1 | Endothelin 1, a potent vasoconstrictor | Vascular responses to BPA may involve endothelin signaling. |
| AR | Androgen receptor, involved in reproductive tissue biology | BPA exposure affects reproductive tissues such as the female prostate. |
| ESRRA | Estrogen-related receptor alpha, involved in metabolic regulation | Estrogen-related pathways may contribute to BPA responses. |
| GPER1 | G protein-coupled estrogen receptor, mediates rapid estrogenic signaling | Relevant to non-classical estrogenic responses to BPA. |
| KEAP1 | Regulator of NRF2 antioxidant response | Oxidative stress pathways are part of BPA toxicity mechanisms. |
How Is response to bisphenol A Regulated?
The response to bisphenol A is regulated at multiple levels. BPA can induce feed-forward estrogenic responses, meaning that initial receptor activation can amplify downstream signaling through estrogen-related pathways. Low-dose effects and non-monotonic dose responses indicate that the response is not simply proportional to dose, and regulatory mechanisms may include receptor desensitization, feedback loops, and metabolic conversion. Hepatic immune modulation by BPA suggests that inflammatory signaling pathways are also subject to regulation during the response. Metabolomic studies show that pathway sensitivity varies across doses, implying that metabolic and nuclear receptor networks shape the overall response.
response to bisphenol A and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| ESR1 | Estrogen signaling and endocrine disruption | Knockout or point-mutation cell lines exposed to BPA to test receptor-dependent responses. |
| IL4 | Allergic inflammation | Mouse food allergy model with oral BPA exposure and cytokine readouts. |
| NOS3 | Cerebrovascular dysfunction | Vascular reactivity assays in middle cerebral artery after BPA exposure. |
| AR | Reproductive tissue toxicity | Rodent models of adult female prostate exposed to BPA. |
| CYP1A1 | Metabolic pathway disruption | Metabolomic and dose-response profiling of BPA-exposed cells or animals. |
Endocrine disruption and reproductive toxicity
BPA is an endocrine-disrupting chemical with adverse health effects that include reproductive toxicity. Exposure to BPA affects reproductive tissues such as the adult female prostate in rodent models, indicating that GO:1903925 is relevant to reproductive organ biology. Because BPA can act at low doses and produce non-monotonic responses, reproductive effects may not follow simple dose-response predictions. These findings link the response to bisphenol A to reproductive health risks.
Immune dysregulation and allergic inflammation
BPA exposure can modulate the hepatic immune response, connecting GO:1903925 to liver immune regulation. In a mouse model of food allergy, oral exposure to BPA exacerbated allergic inflammation, suggesting that the response to BPA can worsen allergic disease. These observations support a role for BPA-responsive pathways in immune-mediated disorders.
Cardiovascular and cerebrovascular effects
BPA exposure modifies the vasoactive response of the middle cerebral artery, indicating that GO:1903925 includes vascular effects that may influence cerebrovascular health. Altered vascular tone can contribute to cardiovascular risk, and the response to BPA may therefore be relevant to vascular disease mechanisms. This connection highlights the need for experimental models that capture vascular responses to BPA.
Metabolic disruption
Dose-response metabolomics has mapped molecular cartography and pathway sensitivity to BPA exposure, revealing that metabolic pathways are remodeled during the response. BPA is associated with adverse health effects that include metabolic toxicity mechanisms. These findings link GO:1903925 to metabolic disruption and suggest that metabolomic profiling can identify sensitive pathways and biomarkers.
From response to bisphenol A-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does a candidate gene mediate BPA-induced gene expression changes? | CRISPR knockout cell line exposed to BPA followed by RNA-seq. |
| Does a specific amino acid residue in a receptor determine BPA sensitivity? | CRISPR point-mutation knock-in cell line with receptor variant. |
| Can a reporter gene track BPA-responsive transcription? | Knock-in of a fluorescent or luciferase reporter at a BPA-responsive locus. |
| Does overexpression of a metabolic enzyme alter BPA pathway sensitivity? | CRISPR overexpression cell model with metabolomic readout. |
| Which genes are required for BPA-induced immune modulation? | Genome-wide CRISPR library screening in immune cells exposed to BPA. |
| Does a candidate gene affect BPA-induced vascular responses? | Ex vivo vascular reactivity assay in knockout or knock-in models. |
How to Study the response to bisphenol A Process
| Method | What It Measures | Typical Application |
|---|---|---|
| RNA-seq | Gene expression changes after BPA exposure | Identifying BPA-responsive genes and pathways. |
| Dose-response metabolomics | Metabolite and pathway changes across doses | Mapping molecular cartography and pathway sensitivity to BPA. |
| Cytokine profiling | Inflammatory mediator levels | Assessing hepatic immune modulation and allergic inflammation. |
| Vascular reactivity assay | Vasoconstriction and vasodilation responses | Measuring BPA effects on cerebral artery function. |
| Reproductive tissue histology | Tissue morphology and pathology | Evaluating BPA effects on reproductive organs. |
| CRISPR knockout screening | Gene requirement for BPA responses | Identifying causal genes in BPA-responsive pathways. |
| Reporter gene assay | Transcriptional activity at BPA-responsive loci | Tracking BPA-induced gene expression in live cells. |
| Estrogenic response assay | Feed-forward estrogenic signaling | Testing BPA and analogue effects on estrogen pathways. |
Transcriptomics and RNA-seq
RNA sequencing is widely used to measure gene expression changes during the response to bisphenol A. Because the QuickGO definition includes gene expression as a key output, RNA-seq can identify BPA-responsive genes and pathways. Dose-response designs are important because BPA can produce non-monotonic effects. Transcriptomic data can be annotated with GO:1903925 to standardize interpretation across studies.
Metabolomics and pathway mapping
Dose-response metabolomics can map molecular cartography and pathway sensitivity to BPA exposure. This approach identifies metabolites and pathways that change after exposure and helps link GO:1903925 to metabolic disruption. Metabolomics is particularly useful for detecting low-dose effects that may not be obvious from single-endpoint assays.
Immunological and inflammatory assays
Immune readouts such as cytokine profiling and hepatic immune response assays are used to study BPA effects on inflammation. In food allergy models, oral BPA exposure exacerbates allergic inflammation, which can be measured by allergic response endpoints. These methods connect GO:1903925 to immune dysregulation.
Vascular and physiological assays
Vascular reactivity assays, such as those performed on the middle cerebral artery, measure how BPA exposure modifies vasoactive responses. Physiological assays in reproductive tissues can assess BPA effects on organ biology. These methods capture the organism-level changes described by GO:1903925.
How CRISPR Can Be Used to Study GO:1903925 response to bisphenol A
Knockout
CRISPR knockout models can remove a candidate gene to test whether it is required for the response to bisphenol A. For example, knocking out an estrogen receptor gene can reveal whether BPA-induced signaling depends on that receptor. Knockout cells or animals exposed to BPA can be compared with wild-type controls using RNA-seq, metabolomics, or immune assays. This approach helps establish causal roles for specific genes in GO:1903925.
Point Mutation
CRISPR point mutation can introduce specific amino acid changes to test how a protein variant affects BPA sensitivity. This is useful for dissecting receptor-ligand interactions and downstream signaling. Point-mutation models can reveal whether a single residue is critical for BPA-induced feed-forward estrogenic responses. They also help distinguish direct effects from compensatory changes in knockout models.
Knock-in
CRISPR knock-in can insert reporters, tags, or humanized sequences at endogenous loci to study BPA responses in a physiological context. For example, a fluorescent reporter knocked into a BPA-responsive gene can track expression changes after exposure. Knock-in models can also humanize a gene to test species-specific responses to BPA. These models support precise measurement of GO:1903925-related activity.
Overexpression
CRISPR overexpression can increase the level of a candidate gene to test whether it is sufficient to alter BPA responses. Overexpressing a metabolic enzyme or receptor can change pathway sensitivity and help map molecular cartography of BPA exposure. Overexpression models are useful when a gene is expected to amplify or buffer the response to BPA. They complement knockout and knock-in approaches in building a causal model of GO:1903925.
How EDITGENE Supports response to bisphenol A Research
Researchers studying response to bisphenol A-related genes often need to determine whether a candidate gene is causally involved in BPA-induced cellular changes or is simply correlated with exposure. CRISPR-based models provide a direct way to test causality by removing, modifying, or increasing the activity of specific genes in BPA-exposed systems. EDITGENE supports this work with knockout, point-mutation, knock-in, and overexpression cell models, as well as CRISPR library screening and bioinformatics services tailored to BPA response studies.
Contact EDITGENE today to design your custom CRISPR model for response to bisphenol A research.
Frequently Asked Questions About response to bisphenol A
What is GO:1903925?
GO:1903925 is the Gene Ontology biological process term for response to bisphenol A. It describes any process that changes a cell or organism's state or activity, such as movement, secretion, enzyme production, or gene expression, as a result of a bisphenol A stimulus.
What is response to bisphenol A?
Response to bisphenol A is the collection of cellular and organismal changes triggered by exposure to BPA, an endocrine-disrupting chemical. It includes changes in gene expression, immune signaling, metabolism, and vascular function.
What genes are involved in response to bisphenol A?
Genes involved include estrogen receptors such as ESR1 and ESR2, inflammatory cytokines such as IL4 and IL13, metabolic enzymes such as CYP1A1, and vascular genes such as NOS3. These are implicated in BPA-responsive pathways across immune, metabolic, and vascular systems.
Why is bisphenol A an endocrine disruptor?
BPA is considered an endocrine disruptor because it can interfere with hormone signaling, including estrogenic pathways, and can induce feed-forward estrogenic responses. It also shows low-dose effects and non-monotonic dose responses.
What are low-dose effects of bisphenol A?
Low-dose effects are biological changes observed at very low BPA concentrations, sometimes below levels used in traditional toxicology studies. Non-monotonic dose responses mean the effect may not increase steadily with dose.
How does bisphenol A affect the immune system?
BPA can modulate the hepatic immune response and exacerbate allergic inflammation in mouse models. This suggests that the response to BPA includes immune-regulatory changes.
Can bisphenol A affect blood vessels?
Yes. BPA exposure modifies the vasoactive response of the middle cerebral artery, indicating that the response to BPA includes cerebrovascular effects.
How do researchers study response to bisphenol A?
Researchers use RNA-seq, dose-response metabolomics, cytokine profiling, vascular reactivity assays, and reproductive tissue histology. CRISPR knockout and knock-in models help test causal roles of specific genes.
What is the role of metabolomics in BPA research?
Dose-response metabolomics maps molecular cartography and pathway sensitivity to BPA exposure. It identifies metabolites and pathways that change after exposure.
How can CRISPR help study GO:1903925?
CRISPR knockout, point mutation, knock-in, and overexpression models can test whether specific genes are required or sufficient for BPA-induced changes. CRISPR library screening can discover new regulators of the response.
Conclusion
GO:1903925, response to bisphenol A, provides a standardized biological process framework for studying how cells and organisms react to BPA exposure. The term encompasses changes in gene expression, enzyme production, secretion, immune signaling, metabolism, and vascular function, and it is supported by diverse experimental evidence. Because BPA acts as an endocrine disruptor with low-dose and non-monotonic effects, the response is complex and requires careful experimental design. CRISPR-based models are powerful tools for dissecting the causal genes and pathways within GO:1903925. By combining knockout, point-mutation, knock-in, overexpression, and library screening approaches with transcriptomic and metabolomic readouts, researchers can move from correlation to mechanism in BPA response research. EDITGENE provides these services to support publication-ready studies of response to bisphenol A.
References
- 1. Ma Y et al.. 2019. The adverse health effects of bisphenol A and related toxicity mechanisms.. Environ Res 176:108575 PMID: 31299621
- 2. Gebru YA et al.. 2023. Modulatory effects of bisphenol A on the hepatic immune response.. Environ Pollut 336:122430 PMID: 37611793
- 3. Karim S et al.. 2022. Bisphenol A analogues induce a feed-forward estrogenic response in zebrafish.. Toxicol Appl Pharmacol 455:116263 PMID: 36195136
- 4. Vandenberg LN et al.. 2012. Hormones and endocrine-disrupting chemicals: low-dose effects and nonmonotonic dose responses.. Endocr Rev 33(3):378-455 PMID: 22419778
- 5. Bedolo CM et al.. 2023. The impacts of exposure to bisphenol A in the adult female prostate Meriones unguiculatus.. Reprod Toxicol 119:108412 PMID: 37224931
- 6. Costa HE et al.. 2025. Bisphenol A Exposure Modifies the Vasoactive Response of the Middle Cerebral Artery.. Int J Mol Sci 26(8) PMID: 40332806
- 7. Misme-Aucouturier B et al.. 2022. Oral exposure to bisphenol A exacerbates allergic inflammation in a mouse model of food allergy.. Toxicology 472:153188 PMID: 35430321
- 8. Zhao H et al.. 2022. Dose-response metabolomics and pathway sensitivity to map molecular cartography of bisphenol A exposure.. Environ Int 158:106893 PMID: 34592654
